Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A market index tracks a group of assets, while a benchmark measures performance against a standard. Understand their roles and limits.
27,218 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Aster broadens its partnership with WLFI to introduce USD1-denominated perpetual contracts and new incentives, design...
Insider stock moves can be routine or signaling. This article breaks down the facts behind ford's farley sells 6,454,...
SoundHound AI reports a 59% rise in Q4 revenue and a narrowed EBITDA loss, yet the stock has fallen year-to-date amid...
A sharp dip can set off alarm bells, but it can also open doors. This article digs into why Qualcomm stock down 28% h...
Dreaming of leaving the workforce early? This guide distills two concrete moves that can make early retirement within...
Bitcoin has fallen about 19% this year, prompting a closer look at three ETF types—spot, futures, and leveraged futur...
Better Home & Finance and Coinbase rolled out a crypto-backed conforming mortgage option that lets qualified borrower...
Argan stock ascended today as investors cheered stronger profits and a brighter outlook for energy infrastructure tie...
Toncoin and MemeCore surged roughly 30% as Bitcoin touched $81,000, signaling renewed trader interest amid a choppy m...
LifeStance Health Group stunned the market with a beat-and-raise quarter, sending its stock up roughly 20%. This deep...
Embecta faced a sharp decline after its quarterly report, leaving investors wondering about the near-term outlook. Th...